Cite
HARVARD Citation
Wijarnpreecha, K. et al. (2021). Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States. Alimentary pharmacology & therapeutics. 54 (4), pp. 481-492. [Online].